Evidence map›Paper›PMID 33902623›Full record

ArticleAIDS research and therapy2021

HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.

Julia Tubert, Laura Packel, Lauren A Hunter, Rashid Mfaume, Prosper Njau, Angela A Ramadhani, Jenny X Liu, Sandra I McCoy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Julia TubertSchool of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA, 94704, USA. juliatubert@berkeley.edu.ORCID 0000-0003-0779-888X
Laura PackelSchool of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA, 94704, USA.
Lauren A HunterSchool of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA, 94704, USA.
Rashid MfaumeShinyanga Regional Medical Office, Shinyanga, Tanzania.
Prosper NjauHealth for a Prosperous Nation, Dar es Salaam, Tanzania.
Angela A RamadhaniNational AIDS Control Programme, Ministry of Health, Community Development, Gender, Elderly, and Children, Dar es Salaam, Tanzania.
Jenny X LiuInstitute for Health and Aging, Bixby Center for Global Reproductive Health, University of California, San Francisco, San Francisco, CA, USA.
Sandra I McCoySchool of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA, 94704, USA.
University of California, Berkeley · USMinistry of Health, Community Development, Gender, Elderly and Children · TZBerkeley Public Health Division · US

Funding

Reaching Adolescent Girls and Young Women through Girl-friendly Drug VendorsR34MH116804 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIU, JENNY XIN, MCCOY, SANDRA I · 2018 to 2019
$663k
National Institute of Mental Health (US) R34MH116804NIMH NIH HHS R34 MH116804
6 · The paper itself

Abstract

backgroundHIV risk remains high among adolescent girls and young women (AGYW, ages 15-24) in Tanzania. Many AGYW experience stigma and provider bias at health facilities, deterring their use of HIV prevention services. Privately-owned drug shops, ubiquitous in many communities, may be an effective and accessible channel to deliver HIV prevention products to AGYW, including oral pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring.

methodsIn July-August 2019, we enrolled 26 drug shops in Shinyanga, Tanzania in an ongoing study to create "girl-friendly" drug shops where AGYW can access HIV self-testing and contraception. At baseline, all shop dispensers were given basic information about oral PrEP and the dapivirine ring and were asked about their interest in stocking each. During the next 3-5 months, we surveyed AGYW (n = 56) customers about their interest in oral PrEP and the ring.

resultsAmong dispensers, the median age was 42 years and 77% were female. Overall, 42% of dispensers had heard of a medication for HIV prevention. Almost all dispensers reported some interest in stocking oral PrEP (92%) and the dapivirine ring (96%). Most (85%) reported they would provide oral PrEP to AGYW who requested it. Among AGYW customers, the median age was 17 years; 29% of AGYW were married or had a steady partner and 18% had children. Only 20% of AGYW had heard of a medication to prevent HIV, yet 64% and 43% expressed some interest in using oral PrEP and the dapivirine ring, respectively, after receiving information about the products. PrEP interest was higher among AGYW who were partnered and had children.

conclusionsDespite low prior awareness of PrEP among shop dispensers and AGYW, we found high levels of interest in oral PrEP and the dapivirine ring in both groups. Community-based drug shops represent a promising strategy to make HIV prevention more accessible to AGYW.

Indexed as

Anti-HIV AgentsHIV InfectionsPharmaceutical PreparationsPre-Exposure ProphylaxisAdolescentAdultChildFemaleHealth Knowledge, Attitudes, PracticeHumansInfant, NewbornPyrimidinesTanzaniaYoung AdultAnti-HIV AgentsDapivirinePharmaceutical PreparationsPyrimidinesAdolescent girlsDapivirine ringDrug shopsHIVHIV preventionLong-acting PrEPPre-exposure prophylaxisPrEPSub-Saharan AfricaTanzaniaYoung women

Identifiers

PMID33902623
PMCPMC8074434
OpenAlexW3111266650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.